(This shared mechanism also explains why substances like fentanyl are so addictive.) GLP-1 receptors arent just located in the gut and pancreas
While these medications have redefined what is possible in weight management by reducing appetite and improving insulin sensitivity, their effectiveness can come with the unintended consequence of losing muscle mass if no structured plan is in place
Seek emergency medical attention (call 999 or attend A&E) if you experience: Severe hypoglycaemia symptoms including confusion, inability to concentrate, slurred speech, or loss of consciousness Persistent vomiting that prevents you from keeping down fluids, raising dehydration risk Severe abdominal pain that is worsening or different from typical Ozempic side effects Signs of pancreatitis including intense upper abdominal pain radiating to the back, fever, or rapid pulse Seizures or altered mental state Inability to maintain blood glucose above 4 mmol/L despite consuming carbohydrates Contact NHS 111 or your GP urgently if you have: Moderate symptoms that are concerning but not immediately life-threatening Blood glucose readings consistently below 4 mmol/L but you remain alert and able to treat yourself Persistent nausea affecting your ability to eat or take other medications Signs of dehydration such as increased thirst, dry mouth, or reduced urination Uncertainty about how to manage the situation safely at home If you are pregnant, planning pregnancy, or breastfeeding Routine GP contact is appropriate when: You have taken a slightly higher dose but are experiencing only mild symptoms You need guidance on when to resume your normal dosing schedule You require advice on preventing future dosing errors For patients taking combination therapy with insulin or sulphonylureas, the threshold for seeking medical help should be lower, as the risk of significant hypoglycaemia is substantially increased
Bubbles in your pen can happen during priming or air can also enter through the injection process
Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
Thus, attributing AFib solely to semaglutide use can be challenging
